NO20080080L - Organiske forbindelser - Google Patents
Organiske forbindelserInfo
- Publication number
- NO20080080L NO20080080L NO20080080A NO20080080A NO20080080L NO 20080080 L NO20080080 L NO 20080080L NO 20080080 A NO20080080 A NO 20080080A NO 20080080 A NO20080080 A NO 20080080A NO 20080080 L NO20080080 L NO 20080080L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- organic compounds
- relates
- novel process
- formula
- Prior art date
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- UXOWGYHJODZGMF-QORCZRPOSA-N Aliskiren Chemical compound COCCCOC1=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=CC=C1OC UXOWGYHJODZGMF-QORCZRPOSA-N 0.000 abstract 1
- 229960004601 aliskiren Drugs 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002461 renin inhibitor Substances 0.000 abstract 1
- 229940086526 renin-inhibitors Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0511686.8A GB0511686D0 (en) | 2005-06-08 | 2005-06-08 | Organic compounds |
| PCT/EP2006/005370 WO2006131304A2 (fr) | 2005-06-08 | 2006-06-06 | Composes organiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080080L true NO20080080L (no) | 2008-01-04 |
Family
ID=34835327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080080A NO20080080L (no) | 2005-06-08 | 2008-01-04 | Organiske forbindelser |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7767831B2 (fr) |
| EP (2) | EP1896411A2 (fr) |
| JP (2) | JP2008542415A (fr) |
| KR (1) | KR20080014011A (fr) |
| CN (1) | CN101193860B (fr) |
| AR (1) | AR054374A1 (fr) |
| AU (1) | AU2006256938B2 (fr) |
| BR (1) | BRPI0611919A2 (fr) |
| CA (1) | CA2608575A1 (fr) |
| EC (1) | ECSP077986A (fr) |
| GB (1) | GB0511686D0 (fr) |
| GT (1) | GT200600208A (fr) |
| IL (1) | IL187004A0 (fr) |
| MA (1) | MA29563B1 (fr) |
| MX (1) | MX2007015418A (fr) |
| NO (1) | NO20080080L (fr) |
| NZ (2) | NZ562889A (fr) |
| PE (2) | PE20091359A1 (fr) |
| RU (1) | RU2418785C2 (fr) |
| SG (1) | SG155209A1 (fr) |
| TN (1) | TNSN07465A1 (fr) |
| TW (1) | TW200716544A (fr) |
| WO (1) | WO2006131304A2 (fr) |
| ZA (1) | ZA200709076B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0521083D0 (en) | 2005-10-17 | 2005-11-23 | Novartis Ag | Organic compounds |
| DE102007049039A1 (de) | 2007-10-11 | 2009-04-16 | Reuter Chemischer Apparatebau Kg | Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung |
| EP2062874B1 (fr) | 2007-11-20 | 2014-12-17 | KRKA, tovarna zdravil, d.d., Novo mesto | Procédé et intermédiaires pour la préparation d'aliskiren |
| CN101952242B (zh) | 2007-12-24 | 2015-05-20 | DPx控股有限公司 | 肾素抑制剂的汇集合成和其中有用的中间产物 |
| EP2189442B1 (fr) | 2008-11-20 | 2014-10-01 | Krka Tovarna Zdravil, D.D., Novo Mesto | Procédé et intermédiaires pour la préparation d'aliskiren |
| AU2010282623B2 (en) * | 2009-08-11 | 2013-12-12 | Massachusetts Institute Of Technology | The ring opening of lactones and lactams |
| US8203005B2 (en) | 2009-10-29 | 2012-06-19 | Carbo Design Llc | Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren |
| WO2011098258A1 (fr) * | 2010-02-10 | 2011-08-18 | Ratiopharm Gmbh | Sels d'aliskirène |
| US8703976B2 (en) | 2011-10-02 | 2014-04-22 | Milan Soukup | Manufacturing process for 8-aryloctanoic acids such as Aliskiren |
| CN111423325A (zh) * | 2020-04-26 | 2020-07-17 | 江苏凯迪恩医药科技有限公司 | 基于蒽醌类药物的双醋瑞因合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4570108A (en) * | 1982-07-06 | 1986-02-11 | Stroede Aake | Protection device for electrical incandescent lamps |
| US5659065A (en) * | 1994-04-18 | 1997-08-19 | Novartis Corporation | Alpha-aminoalkanoic acids and reduction products |
| MY119161A (en) | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
| US5606078A (en) * | 1994-04-18 | 1997-02-25 | Ciba-Geigy Corporation | 3,5-Disubstituted tetrahydrofuran-2-ones |
| CA2121898A1 (fr) * | 1994-04-21 | 1995-10-22 | Stephen Hanessian | Synthese de prototypes d'inhibiteurs de la renine |
| IT1292426B1 (it) * | 1997-06-27 | 1999-02-08 | Nicox Sa | Sali nitrati di ace-inibitori |
| JP2005231999A (ja) * | 2000-03-08 | 2005-09-02 | Banyu Pharmaceut Co Ltd | カルバペネム誘導体の製造方法 |
| KR100690471B1 (ko) | 2000-07-05 | 2007-03-09 | 스페델 파르마 아게 | 치환된 옥타노일 아미드의 제조방법 |
| US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| DK1215201T3 (da) * | 2000-12-14 | 2007-01-29 | Speedel Pharma Ag | Fremgangsmåde til fremstilling af aryloctanylamider |
| GB0419361D0 (en) | 2004-08-31 | 2004-10-06 | Novartis Ag | Organic compounds |
-
2005
- 2005-06-08 GB GBGB0511686.8A patent/GB0511686D0/en not_active Ceased
-
2006
- 2006-05-18 GT GT200600208A patent/GT200600208A/es unknown
- 2006-06-06 CA CA002608575A patent/CA2608575A1/fr not_active Abandoned
- 2006-06-06 US US11/916,875 patent/US7767831B2/en not_active Expired - Fee Related
- 2006-06-06 KR KR1020077028644A patent/KR20080014011A/ko not_active Ceased
- 2006-06-06 WO PCT/EP2006/005370 patent/WO2006131304A2/fr not_active Ceased
- 2006-06-06 CN CN2006800202505A patent/CN101193860B/zh not_active Expired - Fee Related
- 2006-06-06 SG SG200905377-8A patent/SG155209A1/en unknown
- 2006-06-06 BR BRPI0611919-0A patent/BRPI0611919A2/pt not_active IP Right Cessation
- 2006-06-06 NZ NZ562889A patent/NZ562889A/en not_active IP Right Cessation
- 2006-06-06 NZ NZ591010A patent/NZ591010A/en not_active IP Right Cessation
- 2006-06-06 RU RU2007148226/04A patent/RU2418785C2/ru not_active IP Right Cessation
- 2006-06-06 AU AU2006256938A patent/AU2006256938B2/en not_active Ceased
- 2006-06-06 MX MX2007015418A patent/MX2007015418A/es active IP Right Grant
- 2006-06-06 EP EP06754143A patent/EP1896411A2/fr not_active Withdrawn
- 2006-06-06 PE PE2009000932A patent/PE20091359A1/es not_active Application Discontinuation
- 2006-06-06 JP JP2008515124A patent/JP2008542415A/ja active Pending
- 2006-06-06 AR ARP060102357A patent/AR054374A1/es not_active Application Discontinuation
- 2006-06-06 PE PE2006000621A patent/PE20070075A1/es not_active Application Discontinuation
- 2006-06-06 EP EP09005946A patent/EP2080754A3/fr not_active Withdrawn
- 2006-06-07 TW TW095120194A patent/TW200716544A/zh unknown
-
2007
- 2007-10-22 ZA ZA200709076A patent/ZA200709076B/xx unknown
- 2007-10-29 IL IL187004A patent/IL187004A0/en unknown
- 2007-12-07 EC EC2007007986A patent/ECSP077986A/es unknown
- 2007-12-07 TN TNP2007000465A patent/TNSN07465A1/en unknown
- 2007-12-26 MA MA30506A patent/MA29563B1/fr unknown
-
2008
- 2008-01-04 NO NO20080080A patent/NO20080080L/no not_active Application Discontinuation
-
2010
- 2010-06-25 US US12/823,518 patent/US20100274027A1/en not_active Abandoned
-
2012
- 2012-08-07 JP JP2012175078A patent/JP2013028607A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080080L (no) | Organiske forbindelser | |
| NO20082263L (no) | Organiske forbindelser | |
| WO2007091009A3 (fr) | Préparation de delmopinol | |
| NO20092692L (no) | MAPK/ERK kinaseinhibitorer | |
| WO2008117833A1 (fr) | Procédé pour synthétiser un composé peptidique cyclique | |
| CA2665931C (fr) | Derives d'hydrobenzamide en tant qu'inhibiteurs de la proteine hsp90 | |
| TN2009000401A1 (en) | New methods | |
| WO2009127948A8 (fr) | Composés aryl carboxamides à 5 éléments de 4-[3-(aryloxy)benzylidène]-3-méthyl pipéridine utiles comme inhibiteurs de la faah | |
| NO20082005L (no) | Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon | |
| NO20082116L (no) | Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse | |
| WO2008155338A3 (fr) | Composés organiques | |
| BRPI0408160B1 (pt) | Processo para o preparo de ésteres do ácido nicotínico substituído e intermediários de enamina para uso nesse processo | |
| WO2008125592B1 (fr) | PROCÉDÉ PERFECTIONNÉ POUR LA PRÉPARATION D'ESTERS O-CHLOROMÉTHYLPHÉNYLGLYOXYLIQUES, PROCÉDÉ PERFECTIONNÉ DE PRÉPARATION D'ESTERS (E)-2-(2-CHLOROMÉTHYLPHÉNYL)-2-ALCOXIMINOACÉTIQUES, ET NOUVEAUX INTERMÉDIAIRES POUR LEUR PR&Eacute | |
| NO20075618L (no) | Novel compounds as GLP-1 Agonists | |
| AU2002367103A1 (en) | An improved synthesis of ceftiofur intermediate | |
| WO2008103367A3 (fr) | Procédé permettant d'assembler des bibliothèques chimiques d'une grande pureté, et composés proapoptotiques découverts grâce à ce procédé | |
| GB0410134D0 (en) | Organic compounds | |
| NO20073602L (no) | Fremgangsmate for fremstilling av hoyrent meloksikam og meloksikamkaliumsalt | |
| NO20076307L (no) | Fremgangsmater for a fremstille biarylurinstoffer og analoger derav | |
| NO20065789L (no) | Cinnamidforbindelse | |
| WO2007054784A8 (fr) | Procede ameliore de preparation de chlorhydrate de granisetron | |
| Styring et al. | Stereoselective synthesis of a thiazolane amide using molecular recognition in the triazolyl-activated ester intermediate | |
| WO2004091549A3 (fr) | Procede d'obtention d'acides hydroxamiques alpha-substitutes | |
| TH78688A (th) | กรรมวิธีสำหรับการเตรียมไพราโซล | |
| EP1857435A3 (fr) | Procédé de préparation d'aryloxypropylamines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |